InvestorsHub Logo

TPX

Followers 0
Posts 40567
Boards Moderated 4
Alias Born 10/24/2013

TPX

Re: TPX post# 43044

Friday, 11/17/2017 9:17:52 AM

Friday, November 17, 2017 9:17:52 AM

Post# of 50649
Research programme: type 1 diabetes therapeutics - MultiCell Technologies

Alternative Names: MCT 275
Latest Information Update: 04 Nov 2017

At a glance
Originator MultiCell Technologies Inc
Class
Mechanism of Action Immunosuppressants
Orphan Drug Status No
Highest Development Phases

No development reported Type 1 diabetes mellitus
Most Recent Events

04 Nov 2017 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (Parenteral, Injection)
24 May 2006 Preclinical trials in Type-1-diabetes-mellitus in USA (unspecified route)

http://adisinsight.springer.com/drugs/800024474?query=all%3A%28%22multicell+technologies%22%29